Regeneron Pharmaceuticals, which has a plant in Rensselaer County, is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11. Biotechnology company ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

LONDON, May 14 (Reuters) - Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the ...

President Trump signs an executive order to reduce prescription drug costs in the U.S. Discover the changes and potential impacts.

French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for $9.5 billion, sending shares of the ...

Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...

What accounts for all this boldness? Companies have long expressed the desire to get more bang for their branding buck; “Make the logo bigger” is a common refrain among design clients (and one ...

May 9 (UPI) --A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which is scheduled to retire animal testing. Organoid Science ...

Pharmaceutical companies argue that treatments are not compensated at their fair value on the European continent and are therefore pushing for a price increase. But the sector is not struggling.

Regeneron said Monday that it will comply with 23andMe's privacy policies and applicable law. (Scripps News) Maryland governor vetoes reparations bill The Hidden Downsides of Doorbell Cameras ...

security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Holding Co. A biotechnology company based in ...